Showing results (81-90 of 185) with videos related to

Sort By:
Pageof 19
Translational Psychiatry|November 6, 2019
Effect of topiramate on eating behaviours in Prader-Willi syndrome: TOPRADER double-blind randomised placebo-controlled studyAngèle Consoli, Sophie Çabal Berthoumieu, Marie Raffin, et al.
Diabetes & Metabolism|September 20, 2025
Glycemic and renal effects of SGLT2 Inhibitors in Prader-Willi syndrome: Benefits and risksJuliette Jacquot-Thierry, Sarah Chalopin, Héléna Mosbah, et al.
American Journal of Preventive Medicine|July 21, 2023
Correlates of Weight Bias in Adults From the NutriNet-Santé StudyOlivia Branche, Camille Buscail, Sandrine Péneau, et al.
The Journal of Clinical Endocrinology and Metabolism|December 6, 2014
Metabolic and adipose tissue signatures in adults with Prader-Willi syndrome: a model of extreme adiposityDelphine Lacroix, Sandrine Moutel, Muriel Coupaye, et al.
Orphanet Journal of Rare Diseases|February 6, 2022
Quality of life outcomes in two phase 3 trials of setmelanotide in patients with obesity due to LEPR or POMC deficiencyPeter Kühnen, Martin Wabitsch, Julia von Schnurbein, et al.
Pharmacological Research|September 10, 2016
The effect of morbid obesity on morphine glucuronidationCelia Lloret-Linares, Huilong Luo, Alexandra Rouquette, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2025
Impact of Setmelanotide on Metabolic Syndrome Risk in Patients With Bardet-Biedl SyndromeAndrea M Haqq, Christine Poitou, Wendy K Chung, et al.
Obesity Surgery|April 29, 2022
Effect of COVID-19 Lockdowns on Physical Activity, Eating Behavior, Body Weight and Psychological Outcomes in a Post-Bariatric CohortAlice Bellicha, Pierre Bel Lassen, Christine Poitou, et al.
Pageof 19